Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Guacetisal is obtained from the esterification of acetylsalicylic acid. It also guaiacol which has the potential for chronic bronchitis treatment.
説明 | Guacetisal is obtained from the esterification of acetylsalicylic acid. It also guaiacol which has the potential for chronic bronchitis treatment. |
分子量 | 286.28 |
分子式 | C16H14O5 |
CAS No. | 55482-89-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (331.84 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Guacetisal 55482-89-8 Others Inhibitor inhibit inhibitor